Glenmark Pharmaceuticals has announced that its Board of Directors will meet on September 26, 2025, to consider and approve the payment of an interim dividend for the financial year 2025-26. If declared, the revised record date for the payment of the interim dividend will be Friday, October 3, 2025. Shareholders should monitor for updates following the board meeting.
Interim Dividend Meeting
The Board of Directors of Glenmark Pharmaceuticals is scheduled to convene on Friday, September 26, 2025. The primary agenda of the meeting is to consider and approve the payment of an interim dividend to the company’s equity shareholders. This decision pertains to the financial year 2025-26.
Revised Record Date Announcement
Following the board meeting, Glenmark Pharmaceuticals will announce its decision regarding the interim dividend. If the board approves the dividend payout, the revised record date for determining eligible shareholders will be Friday, October 3, 2025. Investors and shareholders are advised to take note of this date.
Source: BSE
